GSK completes acquisition of Aiolos Bio for up to $1.4 bln

GSK said on Thursday
it had completed the acquisition of Aiolos Bio, a clinical-stage
biopharmaceutical company focused on respiratory and
inflammatory conditions.
GSK will pay $1...

Related Keywords

London ,City Of ,United Kingdom ,Jason Neely ,Aiolos Bio ,Pablo Mayo Cerqueiro ,Reuters ,Jiangsu Hengrui Pharmaceuticals Co Ltd ,Markets ,